Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):561-570. doi: 10.1097/QAI.0000000000002504.
The impact of HIV stigma on viral suppression among people living with HIV (PLHIV) is not well characterized.
Twenty-one communities in Zambia and South Africa, nested within the HPTN 071 (PopART) trial.
We analyzed data on viral suppression (<400 copies HIV RNA/mL) among 5662 laboratory-confirmed PLHIV aged 18-44 years who were randomly sampled within the PopART trial population cohort 24 months after enrolment (PC24). We collected data on experiences and internalization of stigma from those PLHIV who self-reported their HIV status (n = 3963/5662) and data on perceptions of stigma from a 20% random sample of all PLHIV (n = 1154/5662). We also measured stigma at the community-level among PLHIV, community members, and health workers. We analyzed the association between individual- and community-level measures of HIV stigma and viral suppression among PLHIV, adjusting for confounding.
Of all 5662 PLHIV, 69.1% were virally suppressed at PC24. Viral suppression was highest among those 3963 cohort participants who self-reported living with HIV and were on ART (88.3%), and lower among those not on treatment (37.5%). Self-identifying PLHIV who reported internalized stigma were less likely to be virally suppressed (75.0%) than those who did not (80.7%; adjusted risk ratio, 0.94 95% CI: 0.89 to 0.98). Experiences, perceptions, and community-level measures of stigma were not associated with viral suppression.
Internalized stigma among PLHIV was associated with a lower level of viral suppression; other dimensions of stigma were not. Stigma reduction approaches that address internalized stigma should be an integral component of efforts to control the HIV epidemic.
艾滋病毒耻辱感对艾滋病毒感染者(PLHIV)病毒抑制的影响尚未得到充分描述。
赞比亚和南非的 21 个社区,嵌套在 HPTN 071(PopART)试验中。
我们分析了在登记后 24 个月(PC24)在 PopART 试验人群队列中随机抽样的 5662 名年龄在 18-44 岁之间的实验室确诊的 PLHIV 中病毒抑制(<400 拷贝 HIV RNA/mL)的数据。我们从那些自我报告 HIV 状况的 PLHIV 中收集了耻辱感的经验和内化数据(n=3963/5662),并从所有 PLHIV 的 20%随机样本中收集了对耻辱感的看法数据(n=1154/5662)。我们还测量了 PLHIV、社区成员和卫生工作者在社区层面的耻辱感。我们分析了个人和社区层面的 HIV 耻辱感指标与 PLHIV 病毒抑制之间的关系,调整了混杂因素。
在所有 5662 名 PLHIV 中,69.1%在 PC24 时病毒抑制。在 3963 名报告自己患有 HIV 并正在接受抗逆转录病毒治疗的队列参与者中,病毒抑制率最高(88.3%),而未接受治疗的参与者则较低(37.5%)。自我报告内化耻辱感的 PLHIV 不太可能被病毒抑制(75.0%),而未报告内化耻辱感的 PLHIV 则为 80.7%(调整后的风险比,0.94;95%CI:0.89 至 0.98)。耻辱感的经历、看法和社区层面的衡量指标与病毒抑制无关。
PLHIV 内化的耻辱感与较低的病毒抑制水平有关;其他耻辱感维度则没有。减少耻辱感的方法应作为控制艾滋病毒流行的努力的一个组成部分。